| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,680 |
3,383 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,254 |
1,813 |
$2K |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
204 |
130 |
$0.00 |
| 99152 |
|
33 |
26 |
$0.00 |
| G9577 |
Patients prescribed opiates for longer than six weeks |
22 |
22 |
$0.00 |
| 4040F |
|
18 |
18 |
$0.00 |
| M1176 |
Patient did not receive two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period |
55 |
37 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
107 |
58 |
$0.00 |
| 20552 |
|
16 |
14 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
315 |
246 |
$0.00 |
| G0030 |
Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user |
98 |
57 |
$0.00 |
| 80305 |
|
330 |
226 |
$0.00 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
256 |
208 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
106 |
92 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
146 |
124 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
49 |
28 |
$0.00 |
| M1170 |
Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period |
47 |
35 |
$0.00 |
| M1174 |
Patient received at least two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period |
35 |
28 |
$0.00 |
| G9578 |
Documentation of signed opioid treatment agreement at least once during opioid therapy |
24 |
24 |
$0.00 |
| M1168 |
Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period |
90 |
54 |
$0.00 |
| 76942 |
|
39 |
33 |
$0.00 |
| G9584 |
Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy |
24 |
24 |
$0.00 |
| G2197 |
Patient screened for unhealthy alcohol use using a systematic screening method and not identified as an unhealthy alcohol user |
344 |
213 |
$0.00 |
| 1036F |
|
160 |
134 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
213 |
138 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
143 |
78 |
$0.00 |
| M1177 |
Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period |
18 |
13 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
282 |
180 |
$0.00 |
| M1173 |
Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period |
160 |
103 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
143 |
78 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
32 |
14 |
$0.00 |
| G9583 |
Patients prescribed opiates for longer than six weeks |
22 |
22 |
$0.00 |